Hypocaloric mediterranean Diet

BEHAVIORAL3 trials

Sponsors

Oslo University Hospital, Azienda Ospedaliero Universitaria Maggiore della Carita, Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud

Conditions

Diabetes Mellitus, Type 2GlomerulopathyHypertensionMetabolic SyndromeNon-alcoholic Fatty Liver DiseaseObesityObesity, AbdominalOverweight or Obesity

Unknown Phase

Hypocaloric Mediterranean Diet or Physical Activity to Lower Cardiometabolic Risk

Oslo University HospitalHypertension, Obesity, Abdominal, Overweight or Obesity

Start: 2023-04-21End: 2025-09-30Target: 90Updated: 2023-05-09

Effects of VLCKD in Metabolic Syndrome

Active, not recruitingNCT05275608

Azienda Ospedaliero Universitaria Maggiore della CaritaDiabetes Mellitus, Type 2, Metabolic Syndrome, Non-alcoholic Fatty Liver Disease +1

Start: 2022-11-07End: 2026-12-01Target: 40Updated: 2026-09-10

Dietary Intervention in Obesity-related Glomerulopathy

Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y SaludGlomerulopathy, Obesity

Start: 2022-07-18End: 2024-09-01Target: 60Updated: 2022-07-25